Looking ahead to a psychedelic 2022

The excellent organisation Psilocybin Alpha has produced a series of reports with Looking ahead to a psychedelic 2022 doing 'what it says on the tin' saying "2022 looks set to be another busy year for the psychedelics space, with a number of late-stage clinical trials commencing or wrapping; important decisions on the table for Oregon’s legal supervised psilocybin therapy rollout in 2023; further (psychedelic) drug policy reform efforts set to progress; and much, much more.  Rather than making cold, hard predictions about what’s sure to be a very psychedelic 2022, we’re going to share some key trends that we’ll be keeping an eye on, and covering, in this new year."

For more psychedelic news and research, visit the psychedelic health professional network homepage.